---
$id: https://graph.org.ai/products/commodity/51131626
$type: Product
source: UNSPSC
code: "51131626"
title: "Camonagrel"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Camonagrel

**UNSPSC Code**: 51131626
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XM930M133O. European Medicines Agency schedules Camonagrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06065MIG. Camonagrel generally arises in the molecular formula C15H16N2O3. The term CAMONAGREL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) Most nations schedule camonagrel under HS 29332990 and SITC 51573. As of Q4 2014, CAMONAGREL remains the US FDA Preferred Term for this commodity. Camonagrel bears US NLM identifiers UMLS ID C0534183 and NCI Concept Code C76006. SMILES: O(C1CC2CCC(C2CC1)C(=O)O)CCN1CCNC1.

